The myopia treatment devices market size has grown strongly in recent years. It will grow from $7.48 billion in 2025 to $8.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising screen exposure, increasing pediatric myopia rates, growing eyewear adoption, urban lifestyle changes, awareness of vision correction.
The myopia treatment devices market size is expected to see strong growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to AI-based eye diagnostics, expansion of ortho-k adoption, growth of laser vision correction, preventive pediatric eye care demand, personalized ophthalmic solutions. Major trends in the forecast period include myopia control lenses, early childhood vision correction, non-surgical vision management, customized vision therapy, minimally invasive laser treatments.
The growing prevalence of eye diseases is expected to drive the expansion of the myopia treatment devices market. Eye diseases encompass a wide range of conditions that affect the eye’s structure or function, potentially leading to vision impairment. The rise in these diseases can be attributed to factors such as aging populations, increased screen time, lifestyle changes, and heightened exposure to environmental pollutants. Myopia treatment devices assist in managing these conditions by slowing myopia progression, enhancing visual clarity, and reducing the risk of complications, offering a proactive approach to maintaining eye health and improving the quality of life for those affected. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that 17.2% of Americans aged 40 and above, approximately 20.5 million individuals, will have cataracts in at least one eye, with this figure projected to exceed 30 million by 2028. This increasing incidence of eye diseases is driving the growth of the myopia treatment devices market.
Major companies operating in the myopia treatment devices market are increasingly focusing on innovation and technological advancements, such as cloud-based orthokeratology platforms, to enhance their competitive positioning and address the rising demand for effective myopia management solutions. Orthokeratology lenses are specially engineered overnight lenses that temporarily reshape the cornea to correct myopia, eliminating the need for daytime corrective eyewear. For example, in March 2025, Bausch + Lomb Corporation, a Canada-based eye health company, introduced Arise, a new orthokeratology lens system in the United States that leverages cloud-based intelligent design tools to enable faster and more accurate lens fitting. The Arise system features FDA-cleared shaping lenses designed for overnight myopia reduction, safely reshaping the cornea while the patient sleeps. This advancement is intended to improve fitting efficiency for eye-care professionals, reduce chair time, and support clinicians in more effectively managing pediatric myopia. Additionally, the system offers real-time data insights and design recommendations, allowing for more precise customization for young patients and improved treatment outcomes.
In January 2023, CooperVision Inc., a US-based contact lens manufacturer, acquired SynergEyes Inc. for an undisclosed amount. This acquisition allows CooperVision to expand its specialty contact lens portfolio, particularly by incorporating SynergEyes' hybrid lens technologies, which are used in the treatment of keratoconus and irregular corneas. SynergEyes is a US-based developer specializing in hybrid contact lenses, including those for myopia treatment.
Major companies operating in the myopia treatment devices market are EssilorLuxottica S.A., Carl Zeiss Meditec AG, Alcon Inc., Hoya Corporation, Bausch & Lomb Incorporated, CooperVision Inc., Johnson & Johnson Vision Care Inc., Topcon Corporation, Menicon Co. Ltd., STAAR Surgical Company, Paragon Vision Sciences Inc., Ziemer Ophthalmic Systems AG, Euclid Systems Corporation, Art Optical Contact Lens Inc., Schwind Eye Tech Solutions GmbH, Kubota Pharmaceutical Holdings Co Ltd., Visioneering Technologies Inc., Eyerising International, Nidek Co Ltd., Falco Linsen AG.
North America was the largest region in the myopia treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the myopia treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the myopia treatment devices market by increasing costs of imported optical components, lenses, and laser system parts. Advanced devices such as excimer lasers and ortho-k lenses are most impacted, particularly in North America and Europe. Despite cost pressures, tariffs have encouraged regional manufacturing, localized lens production, and technological innovation in cost-efficient vision correction devices.
The myopia treatment devices market research report is one of a series of new reports that provides myopia treatment devices market statistics, including myopia treatment devices industry global market size, regional shares, competitors with a myopia treatment devices market share, detailed myopia treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the myopia treatment devices industry. This myopia treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Myopia treatment devices are a range of tools and technologies designed to manage or correct myopia (nearsightedness). These devices employ advanced techniques, such as reshaping the cornea with ortho-K lenses or using atropine drops, to slow myopia progression and improve vision without the need for continuous corrective eyewear.
The main types of myopia treatment devices include eyeglasses, contact lenses, ortho-K lenses, phakic intraocular lenses, and excimer laser refractive surgery devices. Eyeglasses are wearable optical devices created to correct vision issues or protect the eyes. Treatment options include corrective lenses, laser eye surgery, and lens implant surgery, with end users including hospitals, clinics, ophthalmic centers, retail stores, and online platforms.
The myopia treatment devices market consists of sales of orthokeratology (ortho-k) lenses, myopia control contact lenses, atropine eye drops, smart glasses, and peripheral defocus lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The myopia treatment devices market size is expected to see strong growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to AI-based eye diagnostics, expansion of ortho-k adoption, growth of laser vision correction, preventive pediatric eye care demand, personalized ophthalmic solutions. Major trends in the forecast period include myopia control lenses, early childhood vision correction, non-surgical vision management, customized vision therapy, minimally invasive laser treatments.
The growing prevalence of eye diseases is expected to drive the expansion of the myopia treatment devices market. Eye diseases encompass a wide range of conditions that affect the eye’s structure or function, potentially leading to vision impairment. The rise in these diseases can be attributed to factors such as aging populations, increased screen time, lifestyle changes, and heightened exposure to environmental pollutants. Myopia treatment devices assist in managing these conditions by slowing myopia progression, enhancing visual clarity, and reducing the risk of complications, offering a proactive approach to maintaining eye health and improving the quality of life for those affected. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that 17.2% of Americans aged 40 and above, approximately 20.5 million individuals, will have cataracts in at least one eye, with this figure projected to exceed 30 million by 2028. This increasing incidence of eye diseases is driving the growth of the myopia treatment devices market.
Major companies operating in the myopia treatment devices market are increasingly focusing on innovation and technological advancements, such as cloud-based orthokeratology platforms, to enhance their competitive positioning and address the rising demand for effective myopia management solutions. Orthokeratology lenses are specially engineered overnight lenses that temporarily reshape the cornea to correct myopia, eliminating the need for daytime corrective eyewear. For example, in March 2025, Bausch + Lomb Corporation, a Canada-based eye health company, introduced Arise, a new orthokeratology lens system in the United States that leverages cloud-based intelligent design tools to enable faster and more accurate lens fitting. The Arise system features FDA-cleared shaping lenses designed for overnight myopia reduction, safely reshaping the cornea while the patient sleeps. This advancement is intended to improve fitting efficiency for eye-care professionals, reduce chair time, and support clinicians in more effectively managing pediatric myopia. Additionally, the system offers real-time data insights and design recommendations, allowing for more precise customization for young patients and improved treatment outcomes.
In January 2023, CooperVision Inc., a US-based contact lens manufacturer, acquired SynergEyes Inc. for an undisclosed amount. This acquisition allows CooperVision to expand its specialty contact lens portfolio, particularly by incorporating SynergEyes' hybrid lens technologies, which are used in the treatment of keratoconus and irregular corneas. SynergEyes is a US-based developer specializing in hybrid contact lenses, including those for myopia treatment.
Major companies operating in the myopia treatment devices market are EssilorLuxottica S.A., Carl Zeiss Meditec AG, Alcon Inc., Hoya Corporation, Bausch & Lomb Incorporated, CooperVision Inc., Johnson & Johnson Vision Care Inc., Topcon Corporation, Menicon Co. Ltd., STAAR Surgical Company, Paragon Vision Sciences Inc., Ziemer Ophthalmic Systems AG, Euclid Systems Corporation, Art Optical Contact Lens Inc., Schwind Eye Tech Solutions GmbH, Kubota Pharmaceutical Holdings Co Ltd., Visioneering Technologies Inc., Eyerising International, Nidek Co Ltd., Falco Linsen AG.
North America was the largest region in the myopia treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the myopia treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the myopia treatment devices market by increasing costs of imported optical components, lenses, and laser system parts. Advanced devices such as excimer lasers and ortho-k lenses are most impacted, particularly in North America and Europe. Despite cost pressures, tariffs have encouraged regional manufacturing, localized lens production, and technological innovation in cost-efficient vision correction devices.
The myopia treatment devices market research report is one of a series of new reports that provides myopia treatment devices market statistics, including myopia treatment devices industry global market size, regional shares, competitors with a myopia treatment devices market share, detailed myopia treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the myopia treatment devices industry. This myopia treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Myopia treatment devices are a range of tools and technologies designed to manage or correct myopia (nearsightedness). These devices employ advanced techniques, such as reshaping the cornea with ortho-K lenses or using atropine drops, to slow myopia progression and improve vision without the need for continuous corrective eyewear.
The main types of myopia treatment devices include eyeglasses, contact lenses, ortho-K lenses, phakic intraocular lenses, and excimer laser refractive surgery devices. Eyeglasses are wearable optical devices created to correct vision issues or protect the eyes. Treatment options include corrective lenses, laser eye surgery, and lens implant surgery, with end users including hospitals, clinics, ophthalmic centers, retail stores, and online platforms.
The myopia treatment devices market consists of sales of orthokeratology (ortho-k) lenses, myopia control contact lenses, atropine eye drops, smart glasses, and peripheral defocus lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Myopia Treatment Devices Market Characteristics
3. Myopia Treatment Devices Market Supply Chain Analysis
4. Global Myopia Treatment Devices Market Trends and Strategies
5. Myopia Treatment Devices Market Analysis of End Use Industries
7. Global Myopia Treatment Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Myopia Treatment Devices Total Addressable Market (TAM) Analysis for the Market
9. Myopia Treatment Devices Market Segmentation
10. Myopia Treatment Devices Market Regional and Country Analysis
11. Asia-Pacific Myopia Treatment Devices Market
12. China Myopia Treatment Devices Market
13. India Myopia Treatment Devices Market
14. Japan Myopia Treatment Devices Market
15. Australia Myopia Treatment Devices Market
16. Indonesia Myopia Treatment Devices Market
17. South Korea Myopia Treatment Devices Market
18. Taiwan Myopia Treatment Devices Market
19. South East Asia Myopia Treatment Devices Market
20. Western Europe Myopia Treatment Devices Market
21. UK Myopia Treatment Devices Market
22. Germany Myopia Treatment Devices Market
23. France Myopia Treatment Devices Market
24. Italy Myopia Treatment Devices Market
25. Spain Myopia Treatment Devices Market
26. Eastern Europe Myopia Treatment Devices Market
27. Russia Myopia Treatment Devices Market
28. North America Myopia Treatment Devices Market
29. USA Myopia Treatment Devices Market
30. Canada Myopia Treatment Devices Market
31. South America Myopia Treatment Devices Market
32. Brazil Myopia Treatment Devices Market
33. Middle East Myopia Treatment Devices Market
34. Africa Myopia Treatment Devices Market
36. Myopia Treatment Devices Market Competitive Landscape and Company Profiles
37. Myopia Treatment Devices Market Other Major and Innovative Companies
40. Myopia Treatment Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Myopia Treatment Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses myopia treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for myopia treatment devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The myopia treatment devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Eye Glasses; Contact Lenses; Ortho-K Lenses; Phakic Intraocular Lenses; Excimer Laser Refractive Surgery Devices2) By Treatment: Corrective Lenses; Laser Eye Surgery; Lens Implant Surgery
3) By End-Use: Hospitals And Clinics; Ophthalmic Centers; Retail stores; Online Channels
Subsegments:
1) By Eye Glasses: Single Vision Glasses; Multifocal Glasses2) By Contact Lenses: Soft Contact Lenses; Rigid Gas Permeable (RGP) Contact Lenses; Hybrid Contact Lenses
3) By Ortho-K Lenses: Overnight Ortho-K Lenses; Daytime Ortho-K Lenses
4) By Phakic Intraocular Lenses: Anterior Chamber Phakic IOLs; Posterior Chamber Phakic IOLs
5) By Excimer Laser Refractive Surgery Devices: LASIK (Laser-Assisted in Situ Keratomileusis) Devices; PRK (Photorefractive Keratectomy) Devices; SMILE (Small Incision Lenticule Extraction) Devices
Companies Mentioned: EssilorLuxottica S.A.; Carl Zeiss Meditec AG; Alcon Inc.; Hoya Corporation; Bausch & Lomb Incorporated; CooperVision Inc.; Johnson & Johnson Vision Care Inc.; Topcon Corporation; Menicon Co. Ltd.; STAAR Surgical Company; Paragon Vision Sciences Inc.; Ziemer Ophthalmic Systems AG; Euclid Systems Corporation; Art Optical Contact Lens Inc.; Schwind Eye Tech Solutions GmbH; Kubota Pharmaceutical Holdings Co Ltd.; Visioneering Technologies Inc.; Eyerising International; Nidek Co Ltd.; Falco Linsen AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Myopia Treatment Devices market report include:- EssilorLuxottica S.A.
- Carl Zeiss Meditec AG
- Alcon Inc.
- Hoya Corporation
- Bausch & Lomb Incorporated
- CooperVision Inc.
- Johnson & Johnson Vision Care Inc.
- Topcon Corporation
- Menicon Co. Ltd.
- STAAR Surgical Company
- Paragon Vision Sciences Inc.
- Ziemer Ophthalmic Systems AG
- Euclid Systems Corporation
- Art Optical Contact Lens Inc.
- Schwind Eye Tech Solutions GmbH
- Kubota Pharmaceutical Holdings Co Ltd.
- Visioneering Technologies Inc.
- Eyerising International
- Nidek Co Ltd.
- Falco Linsen AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.17 Billion |
| Forecasted Market Value ( USD | $ 11.52 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
